Sunesis Pharmaceuticals - Stock Price History | SNSS

Historical daily share price chart and data for Sunesis Pharmaceuticals since 2020 adjusted for splits. The latest closing stock price for Sunesis Pharmaceuticals as of January 17, 2020 is 0.56.
  • The all-time high Sunesis Pharmaceuticals stock closing price was 264.10 on March 29, 2006.
  • The Sunesis Pharmaceuticals 52-week high stock price is 1.77, which is 216.1% above the current share price.
  • The Sunesis Pharmaceuticals 52-week low stock price is 0.20, which is 64.3% below the current share price.
  • The average Sunesis Pharmaceuticals stock price for the last 52 weeks is 0.76.
Sunesis Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 0.7638 0.4400 1.7400 0.2803 0.3377 -18.76%
2018 2.6765 3.8600 7.3600 0.2400 0.4157 -88.73%
2017 3.0902 3.7599 4.3000 1.8500 3.6900 1.93%
2016 3.8701 5.4025 5.5189 2.7001 3.6200 -32.76%
2015 11.2575 16.4967 21.4757 4.7990 5.3839 -64.80%
2014 30.0973 27.9544 49.3701 6.2987 15.2969 -46.20%
2013 30.7966 25.1350 38.9322 23.9952 28.4343 12.86%
2012 19.2291 7.4985 38.0324 7.3185 25.1950 258.97%
2011 11.3590 18.7125 18.7125 6.4787 7.0186 -62.49%
2010 23.3172 39.2243 52.8988 10.4718 18.7125 -51.40%
2009 14.9871 11.5154 75.2099 5.9376 38.5046 234.37%
2008 47.0879 68.3726 72.3311 11.1555 11.5154 -83.92%
2007 125.8976 166.2355 188.2047 61.1755 71.6114 -55.97%
2006 197.4129 184.9660 264.0984 149.3403 162.6549 -9.24%
2005 197.8255 233.9064 243.2627 167.6929 179.2083 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.062B $0.000B
Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. It has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. It is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.489B 16.53
CSL (CSLLY) Australia $94.378B 0.00
Gilead Sciences (GILD) United States $79.679B 9.87
Vertex Pharmaceuticals (VRTX) United States $60.644B 61.90
Biogen (BIIB) United States $51.516B 8.84
Illumina (ILMN) United States $47.734B 52.37
Regeneron Pharmaceuticals (REGN) United States $42.374B 18.56
Alexion Pharmaceuticals (ALXN) United States $25.066B 12.38
Seattle Genetics (SGEN) United States $18.681B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.631B 0.00
Incyte (INCY) United States $17.339B 40.25
BioMarin Pharmaceutical (BMRN) United States $15.856B 0.00
Genmab (GNMSF) Denmark $13.895B 61.37
Alnylam Pharmaceuticals (ALNY) United States $13.247B 0.00
Galapagos (GLPG) Belgium $12.482B 32.16
Exact Sciences (EXAS) United States $11.433B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $10.404B 0.00
Sarepta Therapeutics (SRPT) United States $9.534B 0.00
Bio-Techne Corp (TECH) United States $8.408B 56.28
QIAGEN (QGEN) Netherlands $8.064B 26.29
Guardant Health (GH) United States $7.944B 0.00
BioNTech SE (BNTX) Germany $7.507B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.192B 18.29
Amarin (AMRN) Ireland $7.112B 0.00
Moderna (MRNA) United States $6.872B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.689B 0.00
Reata Pharmaceuticals (RETA) United States $6.400B 0.00
Exelixis (EXEL) United States $6.022B 16.94
ARGENX SE-ADR (ARGX) Netherlands $5.884B 0.00
Ascendis Pharma (ASND) Denmark $5.862B 0.00
Bluebird Bio (BLUE) United States $5.425B 0.00
Repligen (RGEN) United States $5.243B 95.01
China Biologic Products (CBPO) China $4.558B 25.68
MorphoSys AG (MOR) Germany $4.166B 0.00
Blueprint Medicines (BPMC) United States $3.990B 0.00
Mirati Therapeutics (MRTX) United States $3.827B 0.00
Immunomedics (IMMU) United States $3.675B 0.00
Adaptive Biotechnologies (ADPT) United States $3.508B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.473B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.464B 0.00
MyoKardia (MYOK) United States $3.409B 0.00
NeoGenomics (NEO) United States $3.346B 178.06
CRISPR Therapeutics AG (CRSP) Switzerland $3.220B 0.00
Zai Lab (ZLAB) China $3.085B 0.00
Alkermes (ALKS) Ireland $3.031B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.030B 0.00
Acceleron Pharma (XLRN) United States $2.980B 0.00
UniQure (QURE) Netherlands $2.946B 0.00
Genmab (GMAB) Denmark $2.929B 6.03
Halozyme Therapeutics (HALO) United States $2.926B 0.00
Emergent Biosolutions (EBS) United States $2.868B 28.49
Amicus Therapeutics (FOLD) United States $2.653B 0.00
Epizyme (EPZM) United States $2.434B 0.00
Arena Pharmaceuticals (ARNA) United States $2.339B 5.44
RA PHARMCTL INC (RARX) United States $2.214B 0.00
Denali Therapeutics (DNLI) United States $2.147B 0.00
Myriad Genetics (MYGN) United States $2.136B 31.56
Principia Biopharma (PRNB) United States $2.070B 0.00
Fate Therapeutics (FATE) United States $1.939B 0.00
Zymeworks (ZYME) Canada $1.935B 0.00
Insmed (INSM) United States $1.917B 0.00
REGENXBIO (RGNX) United States $1.774B 0.00
Arvinas (ARVN) United States $1.718B 0.00
Akcea Therapeutics (AKCA) United States $1.601B 0.00
Ligand Pharmaceuticals (LGND) United States $1.588B 30.54
Editas Medicine (EDIT) United States $1.572B 0.00
Alector (ALEC) United States $1.474B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.461B 0.00
Intra-Cellular Therapies (ITCI) United States $1.455B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.390B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.376B 0.00
Coherus BioSciences (CHRS) United States $1.344B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.184B 0.00
DBV Technologies S.A (DBVT) France $1.157B 0.00
Zealand Pharma (ZEAL) Denmark $1.156B 0.00
Codexis (CDXS) United States $1.060B 0.00
Revance Therapeutics (RVNC) United States $1.013B 0.00
Sangamo Therapeutics (SGMO) United States $0.970B 0.00
PHARMA MAR SA (PHMMF) Spain $0.965B 0.00
Pharming Group (PHGUF) Netherlands $0.939B 0.00
Mesoblast (MESO) Australia $0.936B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.902B 0.00
Heska (HSKA) United States $0.845B 215.86
ZIOPHARM Oncology Inc (ZIOP) United States $0.840B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.806B 6.78
Vericel (VCEL) United States $0.781B 291.17
Cellectis S.A (CLLS) France $0.774B 0.00
GENFIT S.A (GNFT) France $0.773B 0.00
Adverum Biotechnologies (ADVM) United States $0.757B 0.00
Twist Bioscience (TWST) United States $0.756B 0.00
ANI Pharmaceuticals (ANIP) United States $0.741B 12.63
NantKwest (NK) United States $0.723B 0.00
Cytokineticsorporated (CYTK) United States $0.717B 0.00
Intellia Therapeutics (NTLA) United States $0.715B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
UROGEN PHARMA (URGN) United States $0.707B 0.00
Sorrento Therapeutics (SRNE) United States $0.701B 0.00
Retrophin (RTRX) United States $0.695B 0.00
Cara Therapeutics (CARA) United States $0.693B 0.00
Anika Therapeutics (ANIK) United States $0.648B 21.03
AC Immune SA (ACIU) Switzerland $0.622B 14.38
Kadmon Holdings (KDMN) United States $0.589B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.578B 0.00
Prothena (PRTA) Ireland $0.569B 0.00
Precision BioSciences (DTIL) United States $0.542B 0.00
Agenus (AGEN) United States $0.541B 0.00
Clovis Oncology (CLVS) United States $0.540B 0.00
BioDelivery Sciences (BDSI) United States $0.522B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.513B 0.00
Dynavax Technologies (DVAX) United States $0.506B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.504B 0.00
Bellus Health (BLU) Canada $0.486B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.473B 0.00
Arcus Biosciences (RCUS) United States $0.469B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.450B 0.00
AnaptysBio (ANAB) United States $0.431B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.429B 2.97
Gritstone Oncology (GRTS) United States $0.402B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.401B 0.00
Merus (MRUS) Netherlands $0.397B 0.00
Mersana Therapeutics (MRSN) United States $0.385B 0.00
Kindred Biosciences (KIN) United States $0.385B 0.00
Puma Biotechnology (PBYI) United States $0.379B 0.00
PDL BioPharma (PDLI) United States $0.372B 9.31
Avid Bioservices (CDMO) United States $0.368B 0.00
Syros Pharmaceuticals (SYRS) United States $0.361B 0.00
Cue Biopharma (CUE) United States $0.354B 0.00
Stemline Therapeutics (STML) United States $0.352B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
CytomX Therapeutics (CTMX) United States $0.339B 0.00
Cellular Biomedicine (CBMG) United States $0.337B 0.00
Inovio Pharmaceuticals (INO) United States $0.329B 0.00
Albireo Pharma (ALBO) United States $0.317B 0.00
Compugen (CGEN) Israel $0.314B 0.00
MannKind (MNKD) United States $0.312B 0.00
Starpharma Holdings (SPHRY) Australia $0.303B 0.00
OSMOTICA PHARM (OSMT) United States $0.302B 0.00
VBI Vaccines (VBIV) United States $0.291B 0.00
IVERIC Bio (ISEE) United States $0.282B 0.00
Geron (GERN) United States $0.282B 0.00
Sutro Biopharma (STRO) United States $0.276B 0.00
WAVE Life Sciences (WVE) Singapore $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.265B 0.00
Kamada (KMDA) Israel $0.263B 7.67
ChromaDex (CDXC) United States $0.260B 0.00
Prometic Life Sciences (LMNL) Canada $0.257B 0.00
Biofrontera AG (BFRA) Germany $0.254B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.245B 0.00
Seres Therapeutics (MCRB) United States $0.240B 0.00
Affimed (AFMD) Germany $0.230B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.230B 0.00
Cerecor (CERC) United States $0.222B 0.00
Theratechnologies (THTX) Canada $0.218B 0.00
XOMA (XOMA) United States $0.215B 0.00
Exicure (XCUR) United States $0.214B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.214B 0.00
Athersys (ATHX) United States $0.199B 0.00
Protagonist Therapeutics (PTGX) United States $0.199B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.198B 0.00
Five Prime Therapeutics (FPRX) United States $0.193B 0.00
Arbutus Biopharma (ABUS) Canada $0.191B 0.00
Novavax (NVAX) United States $0.184B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.184B 0.00
ARAVIVE, INC (ARAV) United States $0.184B 0.00
Fortress Biotech (FBIO) United States $0.183B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.182B 0.00
Alcobra (ARCT) United States $0.180B 0.00
Windtree Therapeutics (WINT) United States $0.172B 0.00
TELA Bio (TELA) United States $0.170B 0.00
Spero Therapeutics (SPRO) United States $0.170B 0.00
PHASEBIO PHARMA (PHAS) United States $0.168B 0.00
Menlo Therapeutics (MNLO) United States $0.163B 0.00
Selecta Biosciences (SELB) United States $0.160B 0.00
Dyadic (DYAI) United States $0.159B 0.00
Aptinyx (APTX) United States $0.154B 0.00
Applied Genetic Technologies (AGTC) United States $0.149B 0.00
Strongbridge Biopharma (SBBP) United States $0.149B 3.97
Verastem (VSTM) United States $0.141B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.130B 0.00
Abeona Therapeutics (ABEO) United States $0.130B 0.00
Arsanis (XFOR) United States $0.129B 0.00
VTv Therapeutics (VTVT) United States $0.128B 0.00
Clearside Biomedical (CLSD) United States $0.126B 0.00
Enzo Biochem (ENZ) United States $0.125B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.121B 0.00
Liquidia Technologies (LQDA) United States $0.120B 0.00
Celyad SA (CYAD) Belgium $0.118B 0.00
Aduro Biotech (ADRO) United States $0.113B 0.00
Antibe Therapeutics (ATBPF) Canada $0.112B 0.00
Happiness Biotech Group (HAPP) China $0.110B 0.00
OvaScience (MLND) United States $0.106B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.102B 0.00
SESEN BIO, INC (SESN) United States $0.102B 0.00
Proteostasis Therapeutics (PTI) United States $0.100B 0.00
Acorda Therapeutics (ACOR) United States $0.099B 0.00
Synlogic (SYBX) United States $0.096B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Emmaus Life Sciences (EMMA) United States $0.090B 0.00
Catalyst Biosciences (CBIO) United States $0.089B 0.00
Orgenesis (ORGS) United States $0.087B 5.63
Adocia (ADOCY) France $0.086B 0.00
Prima BioMed (IMMP) Australia $0.084B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.083B 0.00
Trevena (TRVN) United States $0.081B 0.00
NewLink Genetics (NLNK) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.076B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Checkpoint Therapeutics (CKPT) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Pluristem Therapeutics (PSTI) Israel $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Curis (CRIS) United States $0.057B 0.00
DiaMedica Therapeutics (DMAC) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
AquaBounty Technologies (AQB) United States $0.049B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
Evogene (EVGN) Israel $0.044B 0.00
Soligenix (SNGX) United States $0.043B 0.00
Celldex Therapeutics (CLDX) United States $0.040B 0.00
Celsion (CLSN) United States $0.037B 0.00
BioCardia (BCDA) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Bionano Genomics (BNGO) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Unum Therapeutics (UMRX) United States $0.029B 0.00
VIVUS (VVUS) United States $0.029B 0.00
Novogen (KZIA) Australia $0.029B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
Advaxis (ADXS) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00